Pulse Biosciences (PLSE) Capital Expenditures (2015 - 2025)

Pulse Biosciences' Capital Expenditures history runs 11 years deep, the most recent figure standing at -$202000.0 for Q4 2025.

• In Q4 2025, Capital Expenditures fell 339.13% year-over-year to -$202000.0; the TTM figure through Dec 2025 stood at $8000.0 (down 69.23% YoY), while the FY2025 annual figure was $8000.0, down 69.23% from the prior year.
• Capital Expenditures was -$202000.0 for Q4 2025 at Pulse Biosciences, down from $186000.0 in the prior quarter.
• In the past five years, Capital Expenditures ranged from a high of $279000.0 in Q1 2022 to a low of -$202000.0 in Q4 2025.
• Historically, Capital Expenditures has averaged $49650.0 across 5 years, with a median of $40000.0 in 2022.
• Biggest YoY gain for Capital Expenditures was 800.0% in 2025; the steepest drop was 339.13% in 2025.
• A 5-year view of Capital Expenditures shows it stood at $134000.0 in 2021, then slumped by 69.4% to $41000.0 in 2022, then climbed by 4.88% to $43000.0 in 2023, then sank by 206.98% to -$46000.0 in 2024, then sank by 339.13% to -$202000.0 in 2025.
• The last three Capital Expenditures figures came in at -$202000.0 (Q4 2025), $186000.0 (Q3 2025), and -$21000.0 (Q2 2025), per Business Quant data.